Q&A on the webinar: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance

This Q&A compiles questions asked during the 3 sessions of the webinar on: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance.

Auteurs